<?xml version="1.0" encoding="UTF-8"?>
<p>A global threat emerged in Southern China in 2002 due to the emergence of SARS-CoV that infected 8,098 people with 774 mortalities recorded (
 <xref rid="B3" ref-type="bibr">3</xref>, 
 <xref rid="B5" ref-type="bibr">5</xref>). Furthermore, in 2012, a regional epidemic in the Middle East occurred as a result of the infection with MERS-CoV, causing 2,494 infections and 858 deaths (
 <xref rid="B6" ref-type="bibr">6</xref>). Recently, on December 31, 2019, a new virus that caused the emergence of COVID-19 disease has been identified in Wuhan, China, and it was named SARS-CoV-2 because nearly 70% of its genome is identical to that of SARS-CoV (
 <xref rid="B7" ref-type="bibr">7</xref>, 
 <xref rid="B8" ref-type="bibr">8</xref>). The main targets of SARS-CoV-2 medications include RNA-based RNA polymerase, papain-like protease (PL
 <sup>pro</sup>), 3-chymotrypsin-like protease (3CL
 <sup>pro</sup>), and spike glycoprotein proteins (S protein).
</p>
